Form 8-K - Current report:
SEC Accession No. 0000929638-25-002215
Filing Date
2025-06-10
Accepted
2025-06-10 17:26:39
Documents
14
Period of Report
2025-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 a8k.htm   iXBRL 8-K 42098
2 exhibit10-2.htm EX-10.1 79138
  Complete submission text file 0000929638-25-002215.txt   312112

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA engn-20250610.xsd EX-101.SCH 4383
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE engn-20250610_def.xml EX-101.DEF 17911
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE engn-20250610_lab.xml EX-101.LAB 26902
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE engn-20250610_pre.xml EX-101.PRE 20153
17 EXTRACTED XBRL INSTANCE DOCUMENT a8k_htm.xml XML 6163
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-41854 | Film No.: 251038124
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)